
Orano SA
Long-cycle B2B contracts with nuclear utilities across the full fuel cycle (front end: mining/conversion/enrichment; back end: recycling, packaging, dismantling), sold under multi-year contracts producing a backlog of ~7 years of revenue; plus emerging nuclear-medicine unit (Orano Med)
Values are EUR billions (EUR-USD ~1.10 per the dossier's sourceNote; multiply by ~1.10 for USD). Orano is state-owned, not venture-backed: these are the only disclosed real-money equity events since the 2017 creation from New AREVA. The 2018 point is the only third-party (arm's-length-adjacent) price; the 2017 and 2024 points are French-State subscriptions. The trajectory (EUR ~5bn 2018 -> EUR ~9bn implied 2024) is consistent with the dossier's illustrative base-case equity range of EUR 7.5-9.5bn.
Full financial intelligence for Orano SA
Earnings, margins & COGS, the income-statement breakdown, SWOT, moats & dependencies, the supplier–customer ecosystem graph, top signals & trends, and the valuation range.
- Income statement & margin structure
- SWOT, moats & dependency map
- Supplier–customer ecosystem graph
- Signals, trends & valuation range